Patents by Inventor Peter Seress

Peter Seress has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8101712
    Abstract: The present invention provides a method of preparing and purifying echinocandin-type compounds, such as pneumocandin Bo, WF 11899A, and echinocandin B. These compounds are fermentation products that are used to prepare semi-synthetic products such as the antifungal products Caspofungin, Mycafungin, and Anidulafungin.
    Type: Grant
    Filed: October 16, 2007
    Date of Patent: January 24, 2012
    Assignee: TEVA Gyógyszergyár Zártkör{acute over ())}{acute over (})}úen M{acute over ())}{acute over (})}úköd{acute over ())}{acute over (})}ó Részvénytársaság
    Inventors: Vilmos Keri, Andrea Csorvasi, Peter Seress, Zsolt Tomas Suto
  • Patent number: 7439045
    Abstract: An improved fermentation process for preparing pseudomonic acid A (mupirocin) is disclosed. The metabolically controlled fermentation process provides culturing a Pseudomonas sp. strain in a submerged medium at a temperature within about 20-30° C. The pH of the fermentation medium is regulated to be at about 5.5-6.0 by feeding the fermentation medium with an assimilable carbon source, a mineral salt, or an acidic/alkali solution. Accordingly, the resulting fermentation broth contains an increased yield of highly purified pseudomonic acid A as the main component. The pseudomonic acid B as an impurity in the fermentation broth is significantly decreased.
    Type: Grant
    Filed: June 21, 2002
    Date of Patent: October 21, 2008
    Assignee: TEVA Gyógyszergyár Zártkörúen Müködö Részvénytársaság
    Inventors: Eva Gulyas, Gabor Balogh, Janos Erdei, Peter Seress
  • Publication number: 20080108806
    Abstract: The present invention provides a method of preparing and purifying echinocandin-type compounds, such as pneumocandin Bo, WF 11899A, and echinocandin B. These compounds are fermentation products that are used to prepare semi-synthetic products such as the antifungal products Caspofungin, Mycafungin, and Anidulafungin.
    Type: Application
    Filed: October 16, 2007
    Publication date: May 8, 2008
    Inventors: Vilmos Keri, Andrea Csorvasi, Peter Seress, Zsolt Suto
  • Publication number: 20030027292
    Abstract: An improved fermentation process for preparing pseudomonic acid A (mupirocin) is disclosed. The metabolically controlled fermentation process provides culturing a Pseudomonas sp. strain in a submerged medium at a temperature within about 20-30° C. The pH of the fermentation medium is regulated to be at about 5.5-6.0 by feeding the fermentation medium with an assimilable carbon source, a mineral salt, or an acidic/alkali solution. Accordingly, the resulting fermentation broth contains an increased yield of highly purified pseudomonic acid A as the main component. The pseudomonic acid B as an impurity in the fermentation broth is significantly decreased.
    Type: Application
    Filed: June 21, 2002
    Publication date: February 6, 2003
    Inventors: Eva Gulyas, Gabor Balogh, Janos Erdei, Peter Seress
  • Patent number: 6500651
    Abstract: A method for producing mevinolin by a microorganism in a fermentation process having a seed culture stage and a main fermentation stage, including a) cultivating a microorganism biomass in the seed culture stage to produce an inoculum; b) transferring the inoculum into a fermentation medium in the main fermentation stage; and, c) maintaining steady stage conditions in the main fermentation stage, thereby producing a fermentation broth containing mevinolin. Preferably, the steady state conditions are maintained in the main fermentation stage by one or more of feeding of organic carbon sources; controlling glucose and/or total reducing sugar content; feeding of organic nitrogen sources; controlling pH; controlling foam level; controlling the mass of the fermentation broth by withdrawals and feedings; and, controlling the dissolved oxygen level.
    Type: Grant
    Filed: April 5, 2000
    Date of Patent: December 31, 2002
    Assignee: Biogal Gyogyszergyar Rt.
    Inventors: Péter Seress, Gábor Balogh, Antal Oláh, László Cséke
  • Publication number: 20020197683
    Abstract: A metabolic controlled fermentation process has been developed for the production of carbamoyl tobramycin by the application of different Streptomyces tenebrarius strains in submerged cultures at a temperature within about 37-41° C. on a medium containing assimilable carbon and nitrogen sources, mineral salts and controlling the assimilable carbon and nitrogen sources by feeding in an optimal range. As a result of this invention a high yield production of carbamoyl tobramycin with high purity could be achieved.
    Type: Application
    Filed: January 9, 2002
    Publication date: December 26, 2002
    Inventors: Istvan Bakondi-Kovacs, Ilona Csutoros Novotny, Janos Erdei, Gabor Balogh, Peter Seress
  • Patent number: 6197560
    Abstract: A method for producing lovastatin by a microorganism in a fermentation process having a seed culture stage and a main fermentation stage, including a) cultivating a microorganism biomass in the seed culture stage to produce an inoculum; b) transferring the inoculum into a fermentation medium in the main fermentation stage; and, c) maintaining steady stage conditions in the main fermentation stage, thereby producing a fermentation broth containing lovastatin. Preferably, the steady state conditions are maintained in the main fermentation stage by one or more of feeding of organic carbon sources; controlling glucose and/or total reducing sugar content; feeding of organic and/or inorganic nitrogen sources; controlling pH; controlling foam level; controlling the mass of the fermentation broth by withdrawals and feedings; and, controlling the dissolved oxygen level.
    Type: Grant
    Filed: March 17, 1999
    Date of Patent: March 6, 2001
    Assignee: Biogal Pharmaceutical Company, Ltd.
    Inventors: Péter Seress, Gábor Balogh, Antal Oláh, László Cséke